Page last updated: 2024-12-05

n-acetylalanine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

N-acetylalanine: immunodominant determinant of acidic surface antigen from culture filtrate of human strain of Staph aureus [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

N-acetyl-L-alanine : An N-acetyl-L-amino acid that is L-alanine in which one of the hydrogens attached to the nitrogen is replaced by an acetyl group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID88064
CHEMBL ID1231115
CHEBI ID40992
SCHEMBL ID330009
MeSH IDM0056087

Synonyms (56)

Synonym
AC-19165
acetyl-l-alanine
CHEMBL1231115
chebi:40992 ,
AKOS015837738
97-69-8
n-acetylalanine
n-acetyl-l-alanine
n-acetyl-s-alanine
acetylalanine
alanine, n-acetyl-, l-
n-acetyl-l-alanine, ~99%
(s)-2-(acetylamino)propanoic acid
l-n-acetylalanine
DB02518
ac-ala-oh
2-acetamidopropionic acid
s-(-)-n-acetylalanine
n-acetyl-l-alpha-alanine
139CB1C7-D3CD-42B2-AA12-D5B74EF36071
(2s)-2-acetamidopropanoic acid
M03026
unii-oz9ya0932i
sudismase
sudismase [inn]
oz9ya0932i ,
110294-55-8
n-acetylsuperoxide dismutase (human clone ps 61-10 copper-zinc subunit protein moiety reduced)
(s)-2-acetylamino-propionic acid
AKOS010366966
26c4vy6z0m ,
unii-26c4vy6z0m
nsc 186892
einecs 202-602-0
S3094
SCHEMBL330009
AM81475
(s)-2-acetamidopropanoic acid
n-acetyl alanine
n-acetyl-l-.alpha.-alanine
ch3conhch(ch3)cooh
FD21035
EN300-862647
CS-W004066
n-acetyl-(s)-alanine
(s)-(-)-n-acetylalanine
(s)-n-acetylalanine
(s)-2-acetamidopropionic acid
n-acetyl-l-ala
AYA ,
DTXSID50861704
HY-W004066
Q27093502
AS-19296
(2s)-2-(acetylamino)propanoic acid
Z98655371
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
human metaboliteAny mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
Saccharomyces cerevisiae metaboliteAny fungal metabolite produced during a metabolic reaction in Baker's yeast (Saccharomyces cerevisiae).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
N-acetyl-L-amino acidAn L-amino acid having an N-acetyl substituent.
L-alanine derivativeA proteinogenic amino acid derivative resulting from reaction of L-alanine at the amino group or the carboxy group, or from the replacement of any hydrogen of L-alanine by a heteroatom.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Molecular Functions (3)

Processvia Protein(s)Taxonomy
protein bindingFibrinogen C domain-containing protein 1Homo sapiens (human)
chitin bindingFibrinogen C domain-containing protein 1Homo sapiens (human)
metal ion bindingFibrinogen C domain-containing protein 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (3)

Processvia Protein(s)Taxonomy
membraneFibrinogen C domain-containing protein 1Homo sapiens (human)
collagen-containing extracellular matrixFibrinogen C domain-containing protein 1Homo sapiens (human)
extracellular spaceFibrinogen C domain-containing protein 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Research

Studies (23)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (13.04)18.7374
1990's7 (30.43)18.2507
2000's7 (30.43)29.6817
2010's5 (21.74)24.3611
2020's1 (4.35)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (4.35%)4.05%
Observational0 (0.00%)0.25%
Other22 (95.65%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]